The European Medicines Agency (EMA) has confirmed a suspension notice for Oxbryta (voxelotor, Pfizer), which is used to treat sickle cell disease (SCD). The medicines regulator said that a higher rate ...
Crescent-shaped red blood cells from a sickle cell disease patient in 1972. The disorder affects hemoglobin, the protein in red blood cells that carries oxygen. A genetic mutation causes the cells to ...
The society said it wants to reduce the burden of the disease by pushing the control of the disease to the primary health care level. The Sickle Cell Support Society of Nigeria (SCSSN), an NGO, says ...
RICHMOND, Va. — September is National Sickle Cell Awareness Month. Sickle cell affects 100,000 people in the United States, primarily impacting African Americans. To learn more about the genetic blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback